Tofacitinib for Ulcerative Colitis - A Promising Step Forward

被引：2
作者：
Friedman, Sonia [1 ,2 ]
机构：
[1] Harvard Med Sch, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Ctr Crohns & Colitis, Chestnut Hill, MA 02467 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 376卷 / 18期
关键词：
INFLAMMATORY-BOWEL-DISEASE; JANUS KINASE INHIBITOR; RHEUMATOID-ARTHRITIS; MAINTENANCE THERAPY; INDUCTION;
D O I：
10.1056/NEJMe1701505
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1792 / 1793
页数：2
相关论文
共 10 条
  • [1] Update on Janus Kinase Antagonists in Inflammatory Bowel Disease
    Boland, Brigid S.
    Sandborn, William J.
    Chang, John T.
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2014, 43 (03) : 603 - +
  • [2] JAK inhibition using tofacitinib for inflammatory bowel disease treatment: a hub for multiple inflammatory cytokines
    Danese, Silvio
    Grisham, Matthew
    Hodge, Jennifer
    Telliez, Jean-Baptiste
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2016, 310 (03): : G155 - G162
  • [3] Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Feagan, Brian G.
    Rutgeerts, Paul
    Sands, Bruce E.
    Hanauer, Stephen
    Colombel, Jean-Frederic
    Sandborn, William J.
    Van Assche, Gert
    Axler, Jeffrey
    Kim, Hyo-Jong
    Danese, Silvio
    Fox, Irving
    Milch, Catherine
    Sankoh, Serap
    Wyant, Tim
    Xu, Jing
    Parikh, Asit
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) : 699 - 710
  • [4] Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis
    Fleischmann, Roy
    Kremer, Joel
    Cush, John
    Schulze-Koops, Hendrik
    Connell, Carol A.
    Bradley, John D.
    Gruben, David
    Wallenstein, Gene V.
    Zwillich, Samuel H.
    Kanik, Keith S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06) : 495 - 507
  • [5] Changing epidemiological trends of inflammatory bowel disease in Asia
    Ng, Wee Khoon
    Wong, Sunny H.
    Ng, Siew C.
    [J]. INTESTINAL RESEARCH, 2016, 14 (02) : 111 - 119
  • [6] Next generation of small molecules in inflammatory bowel disease
    Olivera, Pablo
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    [J]. GUT, 2017, 66 (02) : 199 - 209
  • [7] Infliximab for induction and maintenance therapy for ulcerative colitis
    Rutgeerts, P
    Sandborn, WJ
    Feagan, BG
    Reinisch, W
    Olson, A
    Johanns, J
    Travers, S
    Rachmilewitz, D
    Hanauer, SB
    Lichtenstein, GR
    de Villiers, WJS
    Present, D
    Sands, BE
    Colombel, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) : 2462 - 2476
  • [8] Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis
    Sandborn, William J.
    Su, Chinyu
    Sands, Bruce E.
    D'Haens, Geert R.
    Vermeire, Severine
    Schreiber, Stefan
    Danese, Silvio
    Feagan, Brian G.
    Reinisch, Walter
    Niezychowski, Wojciech
    Friedman, Gary
    Lawendy, Nervin
    Yu, Dahong
    Woodworth, Deborah
    Mukherjee, Arnab
    Zhang, Haiying
    Healey, Paul
    Panes, Julian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (18) : 1723 - 1736
  • [9] Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Vranic, Ivana
    Su, Chinyu
    Rousell, Samantha
    Niezychowski, Wojciech
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07) : 616 - 624
  • [10] Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Rheumatoid Arthritis in Open-label, Longterm Extension Studies
    Wollenhaupt, Juergen
    Silverfield, Joel
    Lee, Eun Bong
    Curtis, Jeffrey R.
    Wood, Susan P.
    Soma, Koshika
    Nduaka, Chudy I.
    Benda, Birgitta
    Gruben, David
    Nakamura, Hiroyuki
    Komuro, Yoshihiro
    Zwillich, Samuel H.
    Wang, Lisy
    Riese, Richard J.
    [J]. JOURNAL OF RHEUMATOLOGY, 2014, 41 (05) : 837 - 852
1